Sympathetic signatures of cardiovascular disease: a blueprint for development of targeted sympathetic ablation therapies.
John W
JW
Osborn
Marcos T
MT
Kuroki
D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage*; D000818:Animals; D006321:Heart / Q000294:innervation*; D006333:Heart Failure / Q000188:drug therapy*; D007668:Kidney / Q000294:innervation*; D019808:Losartan / Q000008:administration & dosage*; D013564:Sympathetic Nervous System / Q000503:physiopathology*
D047228:Angiotensin II Type 1 Receptor Blockers; D019808:Losartan